HB220 - AN ACT relating to step therapy protocols.
Kentucky - 2024 Regular Session
Introduced byAmy Neighbors, Danny R. Bentley, Derek Lewis
Last updated 6 months ago
5 Co-Sponsors
Amends KRS 304.17A-163 to permit insurers to require insureds to try biosimilar biological products prior to providing coverage for the equivalent branded prescription drug under certain circumstances; and makes findings and establishes intent of Act.
STATUS
Passed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now